Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 226.4 INR 0.38%
Market Cap: 102.6B INR

Intrinsic Value

The intrinsic value of one MARKSANS stock under the Base Case scenario is 208.8 INR. Compared to the current market price of 226.4 INR, Marksans Pharma Ltd is Overvalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MARKSANS Intrinsic Value
208.8 INR
Overvaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Marksans Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MARKSANS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MARKSANS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Marksans Pharma Ltd
NSE:MARKSANS
IN
Pharmaceuticals
Market Cap
102.6B INR
IPO
Apr 3, 2002
IN
Pharmaceuticals
Market Cap
102.6B INR
IPO
Apr 3, 2002
Price
₹false
EPS
₹false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Marksans Pharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Marksans Pharma Ltd

Current Assets 20.8B
Cash & Short-Term Investments 6.8B
Receivables 5.7B
Other Current Assets 8.3B
Non-Current Assets 8.3B
PP&E 6.9B
Intangibles 1.1B
Other Non-Current Assets 344m
Efficiency

Free Cash Flow Analysis
Marksans Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Marksans Pharma Ltd

Revenue
24.7B INR
Cost of Revenue
-10.9B INR
Gross Profit
13.9B INR
Operating Expenses
-9.6B INR
Operating Income
4.3B INR
Other Expenses
-625.1m INR
Net Income
3.7B INR
Fundamental Scores

MARKSANS Profitability Score
Profitability Due Diligence

Marksans Pharma Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
63/100
Profitability
Score

Marksans Pharma Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

MARKSANS Solvency Score
Solvency Due Diligence

Marksans Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Marksans Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MARKSANS Price Targets Summary
Marksans Pharma Ltd

Wall Street analysts forecast MARKSANS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MARKSANS is 299.88 INR with a low forecast of 267.65 INR and a high forecast of 339.15 INR.

Lowest
Price Target
267.65 INR
18% Upside
Average
Price Target
299.88 INR
32% Upside
Highest
Price Target
339.15 INR
50% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MARKSANS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MARKSANS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MARKSANS stock?

The intrinsic value of one MARKSANS stock under the Base Case scenario is 208.8 INR.

Is MARKSANS stock undervalued or overvalued?

Compared to the current market price of 226.4 INR, Marksans Pharma Ltd is Overvalued by 8%.

Back to Top